Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients.

Autor: Pal P; Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Ibrahim M; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Niu A; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Zwezdaryk KJ; Department of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, USA., Tatje E; Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA., Robinson WR 4th; Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA., Ko L; Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA., Satyavarapu I; Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA., Jones WE; Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Nachabe A; Department of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USA., Luk A; Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Mushatt DM; Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Halvorson K; Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Denson JL; Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Smith CC 3rd; Department of Pulmonary Diseases, Touro LCMC Health, New Orleans, Louisiana, USA., Simeone F; Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Davis G; Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA., Gill SK; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., McDougal A; Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Vigh AS; Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA., Peterson TG; Section of Pathology and Laboratory Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Ning B; Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USA., Hu T; Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USA., Socola F; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Robinson J; Section of Pediatric Infectious Disease, Department of Pediatrics, Tulane University, New Orleans, Louisiana, USA., Safah H; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Saba NS; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.

Publikováno v: Transfusion medicine (Oxford, England) [Transfus Med] 2021 Jun; Vol. 31 (3), pp. 217-220. Date of Electronic Publication: 2020 Oct 19.